Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access
Public ClinicalTrials.gov record NCT01003990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Atazanavir (BMS-232632) for HIV Infected Individuals Completing Atazanavir Clinical Trials: An Extended Access Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to provide atazanavir or tenofovir-emtricitabine to HIV-infected subjects who have completed atazanavir or tenofovir-emtricitabine therapy on a previous BMS sponsored clinical trial and to collect long-term safety information on the treated population.
Study identification
- NCT ID
- NCT01003990
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 710 participants
Conditions and interventions
Conditions
Interventions
- Atazanavir Drug
- Atazanavir/Ritonavir Drug
- Tenofovir/Emtricitabine Drug
- Lopinavir/ritonavir Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2002 (Type not available)
- Primary completion
- Feb 2016 (Actual)
- Completion
- Feb 2016 (Actual)
- Last update posted
- May 11, 2017
2002 – 2016
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Body Positive, Inc | Phoenix | Arizona | 85006 | — |
| Rand Schrader Clinic | Los Angeles | California | 90033 | — |
| St Francis Memorial Hospital | San Francisco | California | 94109 | — |
| Sbma Research, Llc | Miami Beach | Florida | 33139 | — |
| St Josephs Cmprhnsv Rsch Inst | Tampa | Florida | 33607 | — |
| Infectious Disease Of Indiana, Psc | Indianapolis | Indiana | 46218 | — |
| Univ Of Kansas Sch Of Med | Wichita | Kansas | 67214 | — |
| Cri Of New England | Boston | Massachusetts | 02215 | — |
| University Of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Jemsek Clinic | Huntersville | North Carolina | 28078 | — |
| Tarrant County Inf Dis Assoc | Fort Worth | Texas | 76104 | — |
| The Schrader Clinic | Houston | Texas | 77098 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01003990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2017 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01003990 live on ClinicalTrials.gov.